1. Dal Bo M., Rossi F.M., Rossi D., Deambrogi C., Bertoni F., del Giudice I., Palumbo G., Nanni M., Rinaldi A., Kwee I., Tissino E., Corradini G., Gozzetti A., Cencini E., Ladetto M., Coletta A.M., Luciano F., Bulian P., Pozzato G., Laurenti L., Forconi F., di Raimondo F., Marasca R., del Poeta G., Gaidano G., Foa R., Guarini A., Gattei V. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia // Genes Chromosomes Cancer. 2011. 50. (8). 633–643.
2. Döhner H., Stilgenbauer S., Benner A., Leupolt E., Kröber A., Bullinger L., Döhner K., Bentz M., Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia // N. Engl. J. Med. 2000. 343. (26). 1910–1916.
3. Hallek M., Cheson B.D., Catovsky D., Caligaris-Cappio F., Dighiero G., Döhner H., Hillmen P., Keating M., Montserrat E., Chiorazzi N., Stilgenbauer S., Rai K.R., Byr J.C., Eichhorst B., O’Brien S., Robak T., Seymour J.F., Kipps T.J. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL // Blood. 2018. 131. (25). 2745–2760.
4. Hernandez J.A., Rodriguez A.E., Gonzalez M., Benito R., Fontanillo C., Sandoval V., Romero M., Martin-Nunez G., de Coca A.G., Fisac R., Galende J., Recio I., Ortuno F., Garcia J.L., de las Rivas J., Gutierrez N.C., san Miguel J.F., Hernandez J.M. A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia // Haematologica. 2009. 94. (3). 364–371.
5. Hruba M., Subrt I. Multiclonal monoallelic 13q14 interstitial deletion in chronic lymphocytic leukemia // Leuk. Lymphoma. 2013. 54. (2). 413–416.
6. Janssens A., van Roy N., Poppe B., Noens L., Philippe J., Speleman F., Offner F. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature // Eur. J. Haematol. 2012. 89 (1). 72–80.
7. Ouillette P., Collins R., Shakhan S., Li J., Li C., Shedden K., Malek S.N. The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia // Clin. Cancer Res. 2011. 17. (21). 6778–6790.
8. Ouillette P., Erba H., Kujawski L., Kaminski M., Shedden K., Malek S.N. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14 // Cancer Res. 2008. 68. (4). 1012–1021.
9. Rodriguez-Vicente A.E., Diaz M.G., Hernandez-Rivas J.M. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease // Cancer Genet. 2013. 206 (3). 49–62.
10. Van Dyke D.L., Shanafelt T.D., Call T.G., Zent C.S., Smoley S.A., Rabe K.G., Schwager S.M., Sonbert J.C., Slager S.L., Kay N.E. A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia // Br. J. Haematol. 2010. 148. (4). 544–550.
11. Yi S., Li H., Li Z., Хiong W., Liu H., Liu W., Lv R., Yu Z., Zou D., Xu Y., An G., Qiu L. The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study // Int. J. Hematol. 2017. 106. (3). 418–425.
12. Zenz T., Döhner H., Stilgenbauer S. Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia // Best Pract. Res. Clin. Haematol. 2007. 20. (3). 439–453.